Karen Jonscher to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Karen Jonscher has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
1.890
-
Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles throughout the Lifespan and Protects against the Development of Adult NAFLD. Int J Mol Sci. 2022 May 27; 23(11).
Score: 0.714
-
Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. Adv Exp Med Biol. 2019; 1134:33-58.
Score: 0.564
-
Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 2017 04; 31(4):1434-1448.
Score: 0.490
-
Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol. 2017 02; 14(2):81-96.
Score: 0.121